Related Experiment Videos
Dyskinesias associated with tricyclic antidepressants
Summary
Tricyclic antidepressants (TCA) can cause hyperkinetic movement disorders, similar to antipsychotics. These cases suggest drug-induced movement disorders may stem from reduced central nervous system acetylcholine activity, not just increased dopamine.
Area of Science:
- Neuroscience
- Pharmacology
- Movement Disorders
Background:
- Hyperkinetic movement disorders, like tardive dyskinesia, are known side effects of antipsychotic drugs.
- A hyperdopaminergic state induced by neuroleptic compounds is the presumed cause of these extrapyramidal disorders.
Purpose of the Study:
- To investigate the potential for tricyclic antidepressants (TCA) to induce dyskinetic syndromes.
- To explore the neurochemical underpinnings of drug-induced hyperkinetic movement disorders.
Main Methods:
- Observation of two patient cases presenting with dyskinetic syndrome while on tricyclic antidepressants (TCA).
- Analysis of the known pharmacological properties of TCAs, specifically their effects on dopamine and acetylcholine pathways.
Main Results:
- Two patients receiving TCAs developed a dyskinetic syndrome.
- TCAs have minimal impact on striatal dopamine but possess significant anticholinergic activity.
Conclusions:
- Drug-induced hyperkinetic disorders may be linked to diminished central nervous system (CNS) acetylcholine activity.
- These findings support a dual hypothesis involving both reduced acetylcholine and increased dopamine in the etiology of drug-induced hyperkinetic disorders.